Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

PHASE3CompletedINTERVENTIONAL

Enrollment

198

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Japanese Encephalitis

Interventions

BIOLOGICAL

IC51

IC51, 6 mcg, intramuscular (i.m.) booster vaccination 15 months after the primary immunization

Trial Locations (3)

Medizinische Universität Wien, Universitätsklinik für Klinische Pharmakologie, Vienna

Zentrum für Reisemedizin, Dependance für klinische Studien, Vienna

Berliner Zentrum Reise- und Tropenmedizin, Berlin

All Listed Sponsors

lead

Valneva Austria GmbH

INDUSTRY

NCT00595309 - Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51 | Biotech Hunter | Biotech Hunter